Company
Board Member
2024-05-23–present
Nicole Vitullo
Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nicole Vitullo
The company reported in an 8-K filed April 1, 2025 that Nicole Vitullo resigned as director, effective June 1, 2025. The company reported in an 8-K filed May 28, 2024 that Nicole Vitullo was appointed Class II director, effective May 23, 2024.
“On April 1, 2025, Nicole Vitullo notified the Board of Directors (the "Board") of Esperion Therapeutics, Inc. (the "Company") of her decision to resign from the Board, including her positions as a member of the Audit Committee of the Board (the "Audit Committee") and Compliance Committee of the Board, effective June 1, 2025.”
“to elect two Class II director nominees, Antonio M. Gotto Jr., M.D., D.Phil., and Nicole Vitullo, to the Company's Board of Directors, each to hold office until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal "Proposal 1"”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
Board Member
SEC 8-K
Current2024-05-23–present
-
Organization not stated
Board Member
SEC 8-K
2024-05-23–2025-06-01
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Resigned: director
-
Executive change Appointed: Class II director